AG005XD3

97867-33-9 | 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid compound with 2-hydroxypropanoic acid (1:1)

Chemical structure of 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid compound with 2-hydroxypropanoic acid (1:1), CAS 97867-33-9
AG005XD3
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 97867-33-9
Catalog Number AG005XD3(AGN-PC-0JMWSN)
Chemical Name 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid compound with 2-hydroxypropanoic acid (1:1)
IUPAC Name 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;2-hydroxypropanoic acid
InChI InChI=1S/C17H18FN3O3.C3H6O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24;1-2(4)3(5)6/h7-10,19H,1-6H2,(H,23,24);2,4H,1H3,(H,5,6)
InChI Key NRBJWZSFNGZBFQ-UHFFFAOYSA-N
MDL Number MFCD01759747
Molecular Formula C20H24FN3O6
Molecular Weight 421.4195
SMILES OC(C(=O)O)C.C1(CC1)N1C=C(C(C2=CC(=C(C=C12)N1CCNCC1)F)=O)C(=O)O
Synonyms
Ciprofloxacin lactate, 97867-33-9, Cipobacter, Flunase [inj.], 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid compound with 2-hydroxypropanoic acid (1:1), Ificipro, Ciproxin [inj.], Quintor Eye Drops, Ciproflox [inj.], Ciproxina [inj.], Flociprin [inj.], Ciprobid Eye Drops, Ciproxin, Flociprin, UNII-UEY6XFC224, UEY6XFC224, 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid; 2-hydroxypropanoic acid, 3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, mono(2-hydroxypropanoate), 857213-31-1, ciprofloxacin-qacid, Ciproxin (TN), ciprofloxacine lactate, mono(2-hydroxypropanoate), AC1L3Z9Q, ciprofloxacin lactate cp2000, SCHEMBL667608, CHEMBL1077975, CTK8F0635, KS-00000JSL, MFCD01759747, AKOS015896304, API0002029, 96186-80-0, AK307957, AN-34708, DS-11431, SC-75313, LS-141565, TR-038623, FT-0602944, D07702, 213C311, A845757, C-22081, I06-2076, alpha-?hydroxy-?4-?methoxy-?alpha-?(2-?oxopropyl)?-Benzenebutanoic acid? hydrate (1:1), 1-cyclopropyl-6-fluoranyl-4-oxidanylidene-7-piperazin-1-yl-quinoline-3-carboxylic acid; 2-oxidanylpropanoic acid, 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid lactate, 1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 2-hydroxypropanoic acid, 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid,2-hydroxypropanoic acid, 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; 2-hydroxypropanoic acid, 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;2-hydroxypropanoic acid, Ciproflox, Ciproxina, Flunase, C17H18FN3O3.C3H6O3, CID149514, C17-H18-F-N3-O3.C3-H6-O3, Ciprofloxacin lactate, 98% - 100MG 100mg, 85721-33-1,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited